english.prescrire.org > Spotlight > 100 most recent > When to take a safety signal into account: Prescrire's experience

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

When to take a safety signal into account: Prescrire's experience

 Outlook   A large number of safety signals, suggesting the existence of previously unknown or incompletely documented adverse effects, can be found in numerous publications from a wide variety of sources. How can healthcare professionals tell which signals are worth taking into account in order to provide better patient care? This article is based on Prescrire's experience and continuous monitoring of the literature.
Full article (4 pages) available for download by subscribers

©Prescrire 1 January 2024

Source: "When to take a safety signal into account: Prescrire's experience" Prescrire Int 2024; 33 (255): 21-24. Subscribers only.

Enjoy full access to Prescrire International, and support independent information
Share
Share on Facebook Share on Twitter


See also:

"Safety signals:
why bother?"
Prescrire Int 2024;
33 (255): 3.
Free


"When the cause
of a disorder is not
immediately obvious:
could a drug be responsible?"
Prescrire Int 2024;
33 (255): 25-26.
Subscribers only


Read more:

This month's contents

All the subjects in
Prescrire's Spotlight